The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Recombinant Coagulation Factor Concentrate Market Research Report 2024
Synopsis
Coagulation factor is the main drug for the treatment of hemophilia, and it has experienced the evolution and development from the first generation blood-derived coagulation factor products to the second generation recombinant products and the third generation long-acting recombinant products. Recombinant coagulation factors avoid the possibility of human infection and get rid of the dependence on plasma; long-acting products improve patient compliance and treatment convenience by prolonging the half-life of drugs, and long-acting recombinant coagulation factors are the trend of future research and development.
The global Recombinant Coagulation Factor Concentrate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Recombinant Coagulation Factor Concentrate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Coagulation Factor Concentrate.
Report Scope
The Recombinant Coagulation Factor Concentrate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Coagulation Factor Concentrate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Coagulation Factor Concentrate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Alprolix
Benefix
Idelvion
Lxinity
Rebinyn
Rixubis
CSL
Baxalta
Sanofi
Biogen
Pfizer
Novo Disk
Baxter
Wyeth
北京天坛生物制品股份有限公司
上海莱士
泰邦生物
华兰生物
绿十字（中国）生物制品有限公司
Segment by Type
250 IU
500 IU
1000 IU
2000 IU
Segment by Application
Hopistial
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Coagulation Factor Concentrate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Coagulation Factor Concentrate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Coagulation factor is the main drug for the treatment of hemophilia, and it has experienced the evolution and development from the first generation blood-derived coagulation factor products to the second generation recombinant products and the third generation long-acting recombinant products. Recombinant coagulation factors avoid the possibility of human infection and get rid of the dependence on plasma; long-acting products improve patient compliance and treatment convenience by prolonging the half-life of drugs, and long-acting recombinant coagulation factors are the trend of future research and development.
The global Recombinant Coagulation Factor Concentrate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Recombinant Coagulation Factor Concentrate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Coagulation Factor Concentrate.
Report Scope
The Recombinant Coagulation Factor Concentrate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Coagulation Factor Concentrate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Coagulation Factor Concentrate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Alprolix
Benefix
Idelvion
Lxinity
Rebinyn
Rixubis
CSL
Baxalta
Sanofi
Biogen
Pfizer
Novo Disk
Baxter
Wyeth
北京天坛生物制品股份有限公司
上海莱士
泰邦生物
华兰生物
绿十字（中国）生物制品有限公司
Segment by Type
250 IU
500 IU
1000 IU
2000 IU
Segment by Application
Hopistial
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Coagulation Factor Concentrate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Coagulation Factor Concentrate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Recombinant Coagulation Factor Concentrate Market Overview
1.1 Product Overview and Scope of Recombinant Coagulation Factor Concentrate
1.2 Recombinant Coagulation Factor Concentrate Segment by Type
1.2.1 Global Recombinant Coagulation Factor Concentrate Market Value Comparison by Type (2024-2030)
1.2.2 250 IU
1.2.3 500 IU
1.2.4 1000 IU
1.2.5 2000 IU
1.3 Recombinant Coagulation Factor Concentrate Segment by Application
1.3.1 Global Recombinant Coagulation Factor Concentrate Market Value by Application: (2024-2030)
1.3.2 Hopistial
1.3.3 Clinic
1.3.4 Others
1.4 Global Recombinant Coagulation Factor Concentrate Market Size Estimates and Forecasts
1.4.1 Global Recombinant Coagulation Factor Concentrate Revenue 2019-2030
1.4.2 Global Recombinant Coagulation Factor Concentrate Sales 2019-2030
1.4.3 Global Recombinant Coagulation Factor Concentrate Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Recombinant Coagulation Factor Concentrate Market Competition by Manufacturers
2.1 Global Recombinant Coagulation Factor Concentrate Sales Market Share by Manufacturers (2019-2024)
2.2 Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Recombinant Coagulation Factor Concentrate Average Price by Manufacturers (2019-2024)
2.4 Global Recombinant Coagulation Factor Concentrate Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Coagulation Factor Concentrate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Coagulation Factor Concentrate, Product Type & Application
2.7 Recombinant Coagulation Factor Concentrate Market Competitive Situation and Trends
2.7.1 Recombinant Coagulation Factor Concentrate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Recombinant Coagulation Factor Concentrate Players Market Share by Revenue
2.7.3 Global Recombinant Coagulation Factor Concentrate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Recombinant Coagulation Factor Concentrate Retrospective Market Scenario by Region
3.1 Global Recombinant Coagulation Factor Concentrate Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Recombinant Coagulation Factor Concentrate Global Recombinant Coagulation Factor Concentrate Sales by Region: 2019-2030
3.2.1 Global Recombinant Coagulation Factor Concentrate Sales by Region: 2019-2024
3.2.2 Global Recombinant Coagulation Factor Concentrate Sales by Region: 2025-2030
3.3 Global Recombinant Coagulation Factor Concentrate Global Recombinant Coagulation Factor Concentrate Revenue by Region: 2019-2030
3.3.1 Global Recombinant Coagulation Factor Concentrate Revenue by Region: 2019-2024
3.3.2 Global Recombinant Coagulation Factor Concentrate Revenue by Region: 2025-2030
3.4 North America Recombinant Coagulation Factor Concentrate Market Facts & Figures by Country
3.4.1 North America Recombinant Coagulation Factor Concentrate Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Recombinant Coagulation Factor Concentrate Sales by Country (2019-2030)
3.4.3 North America Recombinant Coagulation Factor Concentrate Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Recombinant Coagulation Factor Concentrate Market Facts & Figures by Country
3.5.1 Europe Recombinant Coagulation Factor Concentrate Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Recombinant Coagulation Factor Concentrate Sales by Country (2019-2030)
3.5.3 Europe Recombinant Coagulation Factor Concentrate Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Coagulation Factor Concentrate Market Facts & Figures by Country
3.6.1 Asia Pacific Recombinant Coagulation Factor Concentrate Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Recombinant Coagulation Factor Concentrate Sales by Country (2019-2030)
3.6.3 Asia Pacific Recombinant Coagulation Factor Concentrate Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Recombinant Coagulation Factor Concentrate Market Facts & Figures by Country
3.7.1 Latin America Recombinant Coagulation Factor Concentrate Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Recombinant Coagulation Factor Concentrate Sales by Country (2019-2030)
3.7.3 Latin America Recombinant Coagulation Factor Concentrate Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Coagulation Factor Concentrate Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Coagulation Factor Concentrate Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Recombinant Coagulation Factor Concentrate Sales by Country (2019-2030)
3.8.3 Middle East and Africa Recombinant Coagulation Factor Concentrate Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Recombinant Coagulation Factor Concentrate Sales by Type (2019-2030)
4.1.1 Global Recombinant Coagulation Factor Concentrate Sales by Type (2019-2024)
4.1.2 Global Recombinant Coagulation Factor Concentrate Sales by Type (2025-2030)
4.1.3 Global Recombinant Coagulation Factor Concentrate Sales Market Share by Type (2019-2030)
4.2 Global Recombinant Coagulation Factor Concentrate Revenue by Type (2019-2030)
4.2.1 Global Recombinant Coagulation Factor Concentrate Revenue by Type (2019-2024)
4.2.2 Global Recombinant Coagulation Factor Concentrate Revenue by Type (2025-2030)
4.2.3 Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant Coagulation Factor Concentrate Price by Type (2019-2030)
5 Segment by Application
5.1 Global Recombinant Coagulation Factor Concentrate Sales by Application (2019-2030)
5.1.1 Global Recombinant Coagulation Factor Concentrate Sales by Application (2019-2024)
5.1.2 Global Recombinant Coagulation Factor Concentrate Sales by Application (2025-2030)
5.1.3 Global Recombinant Coagulation Factor Concentrate Sales Market Share by Application (2019-2030)
5.2 Global Recombinant Coagulation Factor Concentrate Revenue by Application (2019-2030)
5.2.1 Global Recombinant Coagulation Factor Concentrate Revenue by Application (2019-2024)
5.2.2 Global Recombinant Coagulation Factor Concentrate Revenue by Application (2025-2030)
5.2.3 Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant Coagulation Factor Concentrate Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Recombinant Coagulation Factor Concentrate Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Alprolix
6.2.1 Alprolix Corporation Information
6.2.2 Alprolix Description and Business Overview
6.2.3 Alprolix Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Alprolix Recombinant Coagulation Factor Concentrate Product Portfolio
6.2.5 Alprolix Recent Developments/Updates
6.3 Benefix
6.3.1 Benefix Corporation Information
6.3.2 Benefix Description and Business Overview
6.3.3 Benefix Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Benefix Recombinant Coagulation Factor Concentrate Product Portfolio
6.3.5 Benefix Recent Developments/Updates
6.4 Idelvion
6.4.1 Idelvion Corporation Information
6.4.2 Idelvion Description and Business Overview
6.4.3 Idelvion Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Idelvion Recombinant Coagulation Factor Concentrate Product Portfolio
6.4.5 Idelvion Recent Developments/Updates
6.5 Lxinity
6.5.1 Lxinity Corporation Information
6.5.2 Lxinity Description and Business Overview
6.5.3 Lxinity Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Lxinity Recombinant Coagulation Factor Concentrate Product Portfolio
6.5.5 Lxinity Recent Developments/Updates
6.6 Rebinyn
6.6.1 Rebinyn Corporation Information
6.6.2 Rebinyn Description and Business Overview
6.6.3 Rebinyn Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Rebinyn Recombinant Coagulation Factor Concentrate Product Portfolio
6.6.5 Rebinyn Recent Developments/Updates
6.7 Rixubis
6.6.1 Rixubis Corporation Information
6.6.2 Rixubis Description and Business Overview
6.6.3 Rixubis Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Rixubis Recombinant Coagulation Factor Concentrate Product Portfolio
6.7.5 Rixubis Recent Developments/Updates
6.8 CSL
6.8.1 CSL Corporation Information
6.8.2 CSL Description and Business Overview
6.8.3 CSL Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CSL Recombinant Coagulation Factor Concentrate Product Portfolio
6.8.5 CSL Recent Developments/Updates
6.9 Baxalta
6.9.1 Baxalta Corporation Information
6.9.2 Baxalta Description and Business Overview
6.9.3 Baxalta Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Baxalta Recombinant Coagulation Factor Concentrate Product Portfolio
6.9.5 Baxalta Recent Developments/Updates
6.10 Sanofi
6.10.1 Sanofi Corporation Information
6.10.2 Sanofi Description and Business Overview
6.10.3 Sanofi Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sanofi Recombinant Coagulation Factor Concentrate Product Portfolio
6.10.5 Sanofi Recent Developments/Updates
6.11 Biogen
6.11.1 Biogen Corporation Information
6.11.2 Biogen Recombinant Coagulation Factor Concentrate Description and Business Overview
6.11.3 Biogen Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Biogen Recombinant Coagulation Factor Concentrate Product Portfolio
6.11.5 Biogen Recent Developments/Updates
6.12 Pfizer
6.12.1 Pfizer Corporation Information
6.12.2 Pfizer Recombinant Coagulation Factor Concentrate Description and Business Overview
6.12.3 Pfizer Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Pfizer Recombinant Coagulation Factor Concentrate Product Portfolio
6.12.5 Pfizer Recent Developments/Updates
6.13 Novo Disk
6.13.1 Novo Disk Corporation Information
6.13.2 Novo Disk Recombinant Coagulation Factor Concentrate Description and Business Overview
6.13.3 Novo Disk Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Novo Disk Recombinant Coagulation Factor Concentrate Product Portfolio
6.13.5 Novo Disk Recent Developments/Updates
6.14 Baxter
6.14.1 Baxter Corporation Information
6.14.2 Baxter Recombinant Coagulation Factor Concentrate Description and Business Overview
6.14.3 Baxter Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Baxter Recombinant Coagulation Factor Concentrate Product Portfolio
6.14.5 Baxter Recent Developments/Updates
6.15 Wyeth
6.15.1 Wyeth Corporation Information
6.15.2 Wyeth Recombinant Coagulation Factor Concentrate Description and Business Overview
6.15.3 Wyeth Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Wyeth Recombinant Coagulation Factor Concentrate Product Portfolio
6.15.5 Wyeth Recent Developments/Updates
6.16 北京天坛生物制品股份有限公司
6.16.1 北京天坛生物制品股份有限公司 Corporation Information
6.16.2 北京天坛生物制品股份有限公司 Recombinant Coagulation Factor Concentrate Description and Business Overview
6.16.3 北京天坛生物制品股份有限公司 Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
6.16.4 北京天坛生物制品股份有限公司 Recombinant Coagulation Factor Concentrate Product Portfolio
6.16.5 北京天坛生物制品股份有限公司 Recent Developments/Updates
6.17 上海莱士
6.17.1 上海莱士 Corporation Information
6.17.2 上海莱士 Recombinant Coagulation Factor Concentrate Description and Business Overview
6.17.3 上海莱士 Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
6.17.4 上海莱士 Recombinant Coagulation Factor Concentrate Product Portfolio
6.17.5 上海莱士 Recent Developments/Updates
6.18 泰邦生物
6.18.1 泰邦生物 Corporation Information
6.18.2 泰邦生物 Recombinant Coagulation Factor Concentrate Description and Business Overview
6.18.3 泰邦生物 Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
6.18.4 泰邦生物 Recombinant Coagulation Factor Concentrate Product Portfolio
6.18.5 泰邦生物 Recent Developments/Updates
6.19 华兰生物
6.19.1 华兰生物 Corporation Information
6.19.2 华兰生物 Recombinant Coagulation Factor Concentrate Description and Business Overview
6.19.3 华兰生物 Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
6.19.4 华兰生物 Recombinant Coagulation Factor Concentrate Product Portfolio
6.19.5 华兰生物 Recent Developments/Updates
6.20 绿十字（中国）生物制品有限公司
6.20.1 绿十字（中国）生物制品有限公司 Corporation Information
6.20.2 绿十字（中国）生物制品有限公司 Recombinant Coagulation Factor Concentrate Description and Business Overview
6.20.3 绿十字（中国）生物制品有限公司 Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
6.20.4 绿十字（中国）生物制品有限公司 Recombinant Coagulation Factor Concentrate Product Portfolio
6.20.5 绿十字（中国）生物制品有限公司 Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Coagulation Factor Concentrate Industry Chain Analysis
7.2 Recombinant Coagulation Factor Concentrate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Coagulation Factor Concentrate Production Mode & Process
7.4 Recombinant Coagulation Factor Concentrate Sales and Marketing
7.4.1 Recombinant Coagulation Factor Concentrate Sales Channels
7.4.2 Recombinant Coagulation Factor Concentrate Distributors
7.5 Recombinant Coagulation Factor Concentrate Customers
8 Recombinant Coagulation Factor Concentrate Market Dynamics
8.1 Recombinant Coagulation Factor Concentrate Industry Trends
8.2 Recombinant Coagulation Factor Concentrate Market Drivers
8.3 Recombinant Coagulation Factor Concentrate Market Challenges
8.4 Recombinant Coagulation Factor Concentrate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Recombinant Coagulation Factor Concentrate Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Recombinant Coagulation Factor Concentrate Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Recombinant Coagulation Factor Concentrate Market Competitive Situation by Manufacturers in 2023
Table 4. Global Recombinant Coagulation Factor Concentrate Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Recombinant Coagulation Factor Concentrate Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Recombinant Coagulation Factor Concentrate Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Recombinant Coagulation Factor Concentrate Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Recombinant Coagulation Factor Concentrate, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Recombinant Coagulation Factor Concentrate, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Recombinant Coagulation Factor Concentrate, Product Type & Application
Table 12. Global Key Manufacturers of Recombinant Coagulation Factor Concentrate, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Recombinant Coagulation Factor Concentrate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Coagulation Factor Concentrate as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant Coagulation Factor Concentrate Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Recombinant Coagulation Factor Concentrate Sales by Region (2019-2024) & (K Units)
Table 18. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Region (2019-2024)
Table 19. Global Recombinant Coagulation Factor Concentrate Sales by Region (2025-2030) & (K Units)
Table 20. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Region (2025-2030)
Table 21. Global Recombinant Coagulation Factor Concentrate Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Region (2019-2024)
Table 23. Global Recombinant Coagulation Factor Concentrate Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Region (2025-2030)
Table 25. North America Recombinant Coagulation Factor Concentrate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Recombinant Coagulation Factor Concentrate Sales by Country (2019-2024) & (K Units)
Table 27. North America Recombinant Coagulation Factor Concentrate Sales by Country (2025-2030) & (K Units)
Table 28. North America Recombinant Coagulation Factor Concentrate Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Recombinant Coagulation Factor Concentrate Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Recombinant Coagulation Factor Concentrate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Recombinant Coagulation Factor Concentrate Sales by Country (2019-2024) & (K Units)
Table 32. Europe Recombinant Coagulation Factor Concentrate Sales by Country (2025-2030) & (K Units)
Table 33. Europe Recombinant Coagulation Factor Concentrate Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Recombinant Coagulation Factor Concentrate Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Recombinant Coagulation Factor Concentrate Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Recombinant Coagulation Factor Concentrate Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Recombinant Coagulation Factor Concentrate Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Recombinant Coagulation Factor Concentrate Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Recombinant Coagulation Factor Concentrate Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Recombinant Coagulation Factor Concentrate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Recombinant Coagulation Factor Concentrate Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Recombinant Coagulation Factor Concentrate Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Recombinant Coagulation Factor Concentrate Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Recombinant Coagulation Factor Concentrate Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Recombinant Coagulation Factor Concentrate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Recombinant Coagulation Factor Concentrate Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Recombinant Coagulation Factor Concentrate Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Recombinant Coagulation Factor Concentrate Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Recombinant Coagulation Factor Concentrate Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Recombinant Coagulation Factor Concentrate Sales (K Units) by Type (2019-2024)
Table 51. Global Recombinant Coagulation Factor Concentrate Sales (K Units) by Type (2025-2030)
Table 52. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Type (2019-2024)
Table 53. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Type (2025-2030)
Table 54. Global Recombinant Coagulation Factor Concentrate Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Recombinant Coagulation Factor Concentrate Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Type (2019-2024)
Table 57. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Type (2025-2030)
Table 58. Global Recombinant Coagulation Factor Concentrate Price (US$/Unit) by Type (2019-2024)
Table 59. Global Recombinant Coagulation Factor Concentrate Price (US$/Unit) by Type (2025-2030)
Table 60. Global Recombinant Coagulation Factor Concentrate Sales (K Units) by Application (2019-2024)
Table 61. Global Recombinant Coagulation Factor Concentrate Sales (K Units) by Application (2025-2030)
Table 62. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Application (2019-2024)
Table 63. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Application (2025-2030)
Table 64. Global Recombinant Coagulation Factor Concentrate Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Recombinant Coagulation Factor Concentrate Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Application (2019-2024)
Table 67. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Application (2025-2030)
Table 68. Global Recombinant Coagulation Factor Concentrate Price (US$/Unit) by Application (2019-2024)
Table 69. Global Recombinant Coagulation Factor Concentrate Price (US$/Unit) by Application (2025-2030)
Table 70. Bayer Corporation Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Bayer Recombinant Coagulation Factor Concentrate Product
Table 74. Bayer Recent Developments/Updates
Table 75. Alprolix Corporation Information
Table 76. Alprolix Description and Business Overview
Table 77. Alprolix Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Alprolix Recombinant Coagulation Factor Concentrate Product
Table 79. Alprolix Recent Developments/Updates
Table 80. Benefix Corporation Information
Table 81. Benefix Description and Business Overview
Table 82. Benefix Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Benefix Recombinant Coagulation Factor Concentrate Product
Table 84. Benefix Recent Developments/Updates
Table 85. Idelvion Corporation Information
Table 86. Idelvion Description and Business Overview
Table 87. Idelvion Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Idelvion Recombinant Coagulation Factor Concentrate Product
Table 89. Idelvion Recent Developments/Updates
Table 90. Lxinity Corporation Information
Table 91. Lxinity Description and Business Overview
Table 92. Lxinity Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Lxinity Recombinant Coagulation Factor Concentrate Product
Table 94. Lxinity Recent Developments/Updates
Table 95. Rebinyn Corporation Information
Table 96. Rebinyn Description and Business Overview
Table 97. Rebinyn Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Rebinyn Recombinant Coagulation Factor Concentrate Product
Table 99. Rebinyn Recent Developments/Updates
Table 100. Rixubis Corporation Information
Table 101. Rixubis Description and Business Overview
Table 102. Rixubis Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Rixubis Recombinant Coagulation Factor Concentrate Product
Table 104. Rixubis Recent Developments/Updates
Table 105. CSL Corporation Information
Table 106. CSL Description and Business Overview
Table 107. CSL Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. CSL Recombinant Coagulation Factor Concentrate Product
Table 109. CSL Recent Developments/Updates
Table 110. Baxalta Corporation Information
Table 111. Baxalta Description and Business Overview
Table 112. Baxalta Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Baxalta Recombinant Coagulation Factor Concentrate Product
Table 114. Baxalta Recent Developments/Updates
Table 115. Sanofi Corporation Information
Table 116. Sanofi Description and Business Overview
Table 117. Sanofi Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Sanofi Recombinant Coagulation Factor Concentrate Product
Table 119. Sanofi Recent Developments/Updates
Table 120. Biogen Corporation Information
Table 121. Biogen Description and Business Overview
Table 122. Biogen Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Biogen Recombinant Coagulation Factor Concentrate Product
Table 124. Biogen Recent Developments/Updates
Table 125. Pfizer Corporation Information
Table 126. Pfizer Description and Business Overview
Table 127. Pfizer Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Pfizer Recombinant Coagulation Factor Concentrate Product
Table 129. Pfizer Recent Developments/Updates
Table 130. Novo Disk Corporation Information
Table 131. Novo Disk Description and Business Overview
Table 132. Novo Disk Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Novo Disk Recombinant Coagulation Factor Concentrate Product
Table 134. Novo Disk Recent Developments/Updates
Table 135. Baxter Corporation Information
Table 136. Baxter Description and Business Overview
Table 137. Baxter Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Baxter Recombinant Coagulation Factor Concentrate Product
Table 139. Baxter Recent Developments/Updates
Table 140. Wyeth Corporation Information
Table 141. Wyeth Description and Business Overview
Table 142. Wyeth Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Wyeth Recombinant Coagulation Factor Concentrate Product
Table 144. Wyeth Recent Developments/Updates
Table 145. 北京天坛生物制品股份有限公司 Corporation Information
Table 146. 北京天坛生物制品股份有限公司 Description and Business Overview
Table 147. 北京天坛生物制品股份有限公司 Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. 北京天坛生物制品股份有限公司 Recombinant Coagulation Factor Concentrate Product
Table 149. 北京天坛生物制品股份有限公司 Recent Developments/Updates
Table 150. 上海莱士 Corporation Information
Table 151. 上海莱士 Description and Business Overview
Table 152. 上海莱士 Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. 上海莱士 Recombinant Coagulation Factor Concentrate Product
Table 154. 上海莱士 Recent Developments/Updates
Table 155. 泰邦生物 Corporation Information
Table 156. 泰邦生物 Description and Business Overview
Table 157. 泰邦生物 Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. 泰邦生物 Recombinant Coagulation Factor Concentrate Product
Table 159. 泰邦生物 Recent Developments/Updates
Table 160. 华兰生物 Corporation Information
Table 161. 华兰生物 Description and Business Overview
Table 162. 华兰生物 Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. 华兰生物 Recombinant Coagulation Factor Concentrate Product
Table 164. 华兰生物 Recent Developments/Updates
Table 165. 绿十字（中国）生物制品有限公司 Corporation Information
Table 166. 绿十字（中国）生物制品有限公司 Description and Business Overview
Table 167. 绿十字（中国）生物制品有限公司 Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. 绿十字（中国）生物制品有限公司 Recombinant Coagulation Factor Concentrate Product
Table 169. 绿十字（中国）生物制品有限公司 Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Recombinant Coagulation Factor Concentrate Distributors List
Table 173. Recombinant Coagulation Factor Concentrate Customers List
Table 174. Recombinant Coagulation Factor Concentrate Market Trends
Table 175. Recombinant Coagulation Factor Concentrate Market Drivers
Table 176. Recombinant Coagulation Factor Concentrate Market Challenges
Table 177. Recombinant Coagulation Factor Concentrate Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Recombinant Coagulation Factor Concentrate
Figure 2. Global Recombinant Coagulation Factor Concentrate Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Recombinant Coagulation Factor Concentrate Market Share by Type in 2023 & 2030
Figure 4. 250 IU Product Picture
Figure 5. 500 IU Product Picture
Figure 6. 1000 IU Product Picture
Figure 7. 2000 IU Product Picture
Figure 8. Global Recombinant Coagulation Factor Concentrate Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Recombinant Coagulation Factor Concentrate Market Share by Application in 2023 & 2030
Figure 10. Hopistial
Figure 11. Clinic
Figure 12. Others
Figure 13. Global Recombinant Coagulation Factor Concentrate Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Recombinant Coagulation Factor Concentrate Market Size (2019-2030) & (US$ Million)
Figure 15. Global Recombinant Coagulation Factor Concentrate Sales (2019-2030) & (K Units)
Figure 16. Global Recombinant Coagulation Factor Concentrate Average Price (US$/Unit) & (2019-2030)
Figure 17. Recombinant Coagulation Factor Concentrate Report Years Considered
Figure 18. Recombinant Coagulation Factor Concentrate Sales Share by Manufacturers in 2023
Figure 19. Global Recombinant Coagulation Factor Concentrate Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Recombinant Coagulation Factor Concentrate Players: Market Share by Revenue in 2023
Figure 21. Recombinant Coagulation Factor Concentrate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Recombinant Coagulation Factor Concentrate Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Recombinant Coagulation Factor Concentrate Sales Market Share by Country (2019-2030)
Figure 24. North America Recombinant Coagulation Factor Concentrate Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Recombinant Coagulation Factor Concentrate Sales Market Share by Country (2019-2030)
Figure 28. Europe Recombinant Coagulation Factor Concentrate Revenue Market Share by Country (2019-2030)
Figure 29. Germany Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Recombinant Coagulation Factor Concentrate Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Recombinant Coagulation Factor Concentrate Revenue Market Share by Region (2019-2030)
Figure 36. China Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Recombinant Coagulation Factor Concentrate Sales Market Share by Country (2019-2030)
Figure 47. Latin America Recombinant Coagulation Factor Concentrate Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Recombinant Coagulation Factor Concentrate Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Recombinant Coagulation Factor Concentrate Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.A.E Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Recombinant Coagulation Factor Concentrate by Type (2019-2030)
Figure 57. Global Revenue Market Share of Recombinant Coagulation Factor Concentrate by Type (2019-2030)
Figure 58. Global Recombinant Coagulation Factor Concentrate Price (US$/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Recombinant Coagulation Factor Concentrate by Application (2019-2030)
Figure 60. Global Revenue Market Share of Recombinant Coagulation Factor Concentrate by Application (2019-2030)
Figure 61. Global Recombinant Coagulation Factor Concentrate Price (US$/Unit) by Application (2019-2030)
Figure 62. Recombinant Coagulation Factor Concentrate Value Chain
Figure 63. Recombinant Coagulation Factor Concentrate Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
